K. Melich

Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design.

O. Sartor, L. Gomella, P. Gagnier, 2009, The Canadian journal of urology.

Effect of dutasteride on prostate cancer progression and cancer diagnosis on rebiopsy in the REDEEM active surveillance study.

M. Lucia, N. Fleshner, R. Rittmaster, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

78 EFFECT OF BASELINE CHARACTERISTICS ON RELATIVE RISK OF PROSTATE CANCER PROGRESSION IN THE REDUCTION BY DUTASTERIDE OF CLINICAL PROGRESSION EVENTS IN EXPECTANT MANAGEMENT (REDEEM) TRIAL

M. Lucia, N. Fleshner, R. Rittmaster, 2011 .